Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
IntroductionIntegrating interaction data with biological knowledge can be a critical approach for drug development or drug repurposing. In this context, host-pathogen-protein-protein interaction (HP-PPI) networks are useful instrument to uncover the phenomena underlying therapeutic effects in infect...
Main Authors: | Medi Kori, Beste Turanli, Kazim Yalcin Arga |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1096081/full |
Similar Items
-
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
by: Medi Kori, et al.
Published: (2022-06-01) -
Drug Repositioning for Effective Prostate Cancer Treatment
by: Beste Turanli, et al.
Published: (2018-05-01) -
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
by: Hande Beklen, et al.
Published: (2020-08-01) -
Pathogen-driven cancers from a structural perspective: Targeting host-pathogen protein-protein interactions
by: Emine Sila Ozdemir, et al.
Published: (2023-02-01) -
Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.
by: Medi Kori, et al.
Published: (2018-01-01)